[Portopulmonary hypertension: Updated review]. / Hipertensión portopulmonar: Revisión actualizada.
Arch Cardiol Mex
; 88(1): 25-38, 2018.
Article
en Es
| MEDLINE
| ID: mdl-27986561
ABSTRACT
Portopulmonary hypertension (PPH) is a rare condition worldwide, although epidemiological data are unknown in Mexico. However, chronic liver diseases are very prevalent in Mexico. PPH is the 4th subtype in frequency in the group of pulmonary arterial hypertension. Its diagnosis is made within 2 scenarios patients with suspected pulmonary hypertension and candidates for orthotopic liver transplantation (OLT). Both echocardiogram and a right cardiac catheterisation are crucial for diagnosis in both cases. PPH is a challenge for OLT, since it can significantly increase perioperative mortality. The use of specific therapy is the cornerstone of this disease, as a measure to improve the outcome of those who become candidates for OLT with moderate to severe PPH. It is important to recognise that PPH can be a contraindication to OLT. The role of lung-liver transplantation or heart-lung-liver transplantation as a measure to heal pulmonary vascular disease in patients with PPH is still uncertain.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Hipertensión Portal
/
Hipertensión Pulmonar
Tipo de estudio:
Diagnostic_studies
Límite:
Humans
Idioma:
Es
Revista:
Arch Cardiol Mex
Asunto de la revista:
CARDIOLOGIA
Año:
2018
Tipo del documento:
Article